Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
出版年份 2019 全文链接
标题
Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
作者
关键词
-
出版物
Open Forum Infectious Diseases
Volume 6, Issue Supplement_1, Pages S34-S46
出版商
Oxford University Press (OUP)
发表日期
2019-03-16
DOI
10.1093/ofid/ofy293
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years
- (2018) Consuelo Velázquez-Acosta et al. SUPPORTIVE CARE IN CANCER
- High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial
- (2017) J Nowak et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
- (2016) Lindsey M. Weiner et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Acinetobacter dijkshoorniae sp. nov., a member of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex mainly recovered from clinical samples in different countries
- (2016) INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Clinical outcomes using minocycline for Stenotrophomonas maltophilia infections
- (2016) Shauna Jacobson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment ofStenotrophomonas maltophiliainfections
- (2016) Elizabeth Hand et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii
- (2015) William F. Penwell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet report
- (2015) Ana Tereza R. Vasconcelos et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Community-acquiredAcinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis
- (2015) Carina Dexter et al. Expert Review of Anti-Infective Therapy
- Task force on management and prevention of Acinetobacter baumannii infections in the ICU
- (2015) José Garnacho-Montero et al. INTENSIVE CARE MEDICINE
- Acinetobacter seifertii sp. nov., a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens
- (2015) A. Nemec et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives
- (2015) Camila Rizek et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Distribution of Class 1 Integrons,sul1andsul2Genes Among Clinical Isolates ofStenotrophomonas maltophiliafrom a Tertiary Care Hospital in North India
- (2015) Parvinder Kaur et al. Microbial Drug Resistance
- Evaluation of Clonality and Carbapenem Resistance Mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus Complex and Enterobacteriaceae Isolates Collected in European and Mediterranean Countries and Detection of Two Novel β-Lactamases, GES-22 and VIM-35
- (2014) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections
- (2014) David J. Ritchie et al. CLINICAL INFECTIOUS DISEASES
- Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections
- (2013) Yu Lin Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?
- (2013) Sun Young Cho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam
- (2013) MS Oliveira et al. Clinics
- Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates
- (2013) Hae-Sun Chung et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- The value of single-pathogen antibacterial agents
- (2013) Brad Spellberg et al. NATURE REVIEWS DRUG DISCOVERY
- Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
- (2012) Raffaele Zarrilli et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
- (2012) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review
- (2012) M. Garazi et al. JOURNAL OF HOSPITAL INFECTION
- Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy
- (2009) R.E. Mendes et al. CLINICAL MICROBIOLOGY AND INFECTION
- Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature
- (2009) Matthew E Falagas et al. Future Microbiology
- Stenotrophomonas maltophiliadrug resistance
- (2009) Maria B Sanchez et al. Future Microbiology
- Risk Factors for Mortality in Patients with Nosocomial Stenotrophomonas maltophilia Pneumonia
- (2009) Chia-Cheng Tseng et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Global spread of carbapenem-resistant Acinetobacter baumannii
- (2009) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin
- (2008) M. D. David et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program
- (2008) R. E. Mendes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence and Clonal Dissemination of OXA-24- and OXA-58-Producing Acinetobacter baumannii Strains in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance Program
- (2008) M. Castanheira et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites
- (2008) D. Gur et al. JOURNAL OF MEDICAL MICROBIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started